Literature DB >> 28573445

Cardiac Arrhythmias in Patients with Exacerbation of COPD.

Tomasz Rusinowicz1, Tadeusz M Zielonka2, Katarzyna Zycinska2.   

Abstract

Supraventricular and ventricular arrhythmias are common among patients with chronic obstructive pulmonary disease (COPD). Multiple factors can contribute to the development of arrhythmias in patients with exacerbation of the disease, including: respiratory or heart failure, hypertension, coronary disease and also medications. In the present study we seek to determine the prevalence of cardiac arrhythmias and risk factors among patients with exacerbation of COPD. The study was a retrospective evaluation of 2753 24-h Holter recordings of patients hospitalized in 2004-2016. Exacerbation of COPD was diagnosed in 152 patients and the prevalence of arrhythmias in this group of patients was 97%. The commonest arrhythmia was ventricular premature beats (VPB) - 88.8%, followed by supraventricular premature beats (SPB) - 56.5%. Permanent atrial fibrillation accounted for 30.3% and paroxysmal atrial fibrillation (PAF) for 12.5%. Supraventricular tachycardia (SVT) was noted in 34.2% patients and ventricular tachycardia in 25.6%. Respiratory failure increased the risk of SPB, while heart failure increased the risk of VPB. Treatment with theophylline was associated with a higher proportion of PAF and SVT. In conclusion, COPD exacerbation is associated with a high prevalence of cardiac arrhythmias. COPD treatment and comorbidities increase the risk of arrhythmias.

Entities:  

Keywords:  Adverse effects; Arrhythmias; COPD exacerbation; Comorbidities; ECG monitoring; Risk factors

Mesh:

Year:  2017        PMID: 28573445     DOI: 10.1007/5584_2017_41

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  8 in total

1.  Low-dose theophylline in addition to ICS therapy in COPD patients: A systematic review and meta-analysis.

Authors:  Tiankui Shuai; Chuchu Zhang; Meng Zhang; Yalei Wang; Huaiyu Xiong; Qiangru Huang; Jian Liu
Journal:  PLoS One       Date:  2021-05-24       Impact factor: 3.240

2.  Impact of chronic obstructive pulmonary disease and frailty on long-term outcomes and quality of life after transcatheter aortic valve implantation.

Authors:  Artur Dziewierz; Tomasz Tokarek; Pawel Kleczynski; Danuta Sorysz; Maciej Bagienski; Lukasz Rzeszutko; Dariusz Dudek
Journal:  Aging Clin Exp Res       Date:  2017-11-28       Impact factor: 3.636

3.  Clinical outcomes of theophylline use as add-on therapy in patients with chronic obstructive pulmonary disease: A propensity score matching analysis.

Authors:  Preyanate Wilairat; Kirati Kengkla; Chaiyawat Thayawiwat; Phongsathorn Phlaisaithong; Supakorn Somboonmee; Surasak Saokaew
Journal:  Chron Respir Dis       Date:  2019 Jan-Dec       Impact factor: 2.444

4.  Risk factors for new-onset atrial fibrillation in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.

Authors:  Qiangru Huang; Huaiyu Xiong; Tiankui Shuai; Meng Zhang; Chuchu Zhang; Yalei Wang; Lei Zhu; Jiaju Lu; Jian Liu
Journal:  PeerJ       Date:  2020-12-02       Impact factor: 2.984

5.  Association between chronic obstructive pulmonary disease and ventricular arrhythmia: a nationwide population-based cohort study.

Authors:  Chun-Chao Chen; Cheng-Hsin Lin; Wen-Rui Hao; Chun-Chih Chiu; Yu-Ann Fang; Ju-Chi Liu; Li-Chin Sung
Journal:  NPJ Prim Care Respir Med       Date:  2021-02-12       Impact factor: 2.871

Review 6.  Triple Therapy in COPD: Can We Welcome the Reduction in Cardiovascular Risk and Mortality?

Authors:  Paolo Solidoro; Carlo Albera; Fulvia Ribolla; Michela Bellocchia; Luisa Brussino; Filippo Patrucco
Journal:  Front Med (Lausanne)       Date:  2022-03-23

7.  ECG Abnormalities in Patients with Acute Exacerbation of Bronchiectasis and Factors Associated with High Probability of Abnormality.

Authors:  Fatima Alhamed Alduihi
Journal:  Pulm Med       Date:  2021-07-05

8.  Association of asthma-chronic obstructive pulmonary disease overlap syndrome with coronary artery disease, cardiac dysrhythmia and heart failure: a population-based retrospective cohort study.

Authors:  Jun-Jun Yeh; Yu-Feng Wei; Cheng-Li Lin; Wu-Huei Hsu
Journal:  BMJ Open       Date:  2017-10-05       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.